EBF:NYSEEnnis, Inc. Analysis
Data as of 2026-06-30 - not real-time
$21.66
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Ennis, Inc. (EBF) is trading at $21.66, comfortably above its 20‑day SMA (~$20.75) and 50‑day SMA (~$20.55), indicating short‑term momentum. Technical indicators are bullish, with a MACD histogram of +0.14 and a bullish MACD signal, while the stock sits near the upper end of its support zone ($19.99) and below the identified resistance ($21.90). Fundamentally, the company appears attractively priced: the trailing P/E of 12.97 is well below the industry average of 31.74, and the DCF‑derived fair value of $27.12 suggests roughly a 10‑11% upside. Revenue growth is modest at 1.5% YoY, but margins are solid (gross 30.8%, operating 13.8%) and cash flow is healthy, supporting a 4.62% dividend yield with a payout ratio under 60%. The balance sheet is strong, with cash of $49M dwarfing a modest debt load of $3.8M, resulting in a low beta (0.28) and a relatively low overall volatility of 25% over the past 30 days. The company’s exposure is primarily domestic, reducing geographic and currency risks, though the industrial sector can be cyclical. Given the convergence of bullish technicals, attractive valuation, and sustainable dividend, the stock presents a compelling short‑to‑medium‑term opportunity, while the longer‑term outlook remains cautiously optimistic pending broader economic trends.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and price above short‑term SMAs
- Support level intact and price below resistance
- Undervalued relative to DCF fair value
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Attractive P/E versus industry peers
- Strong cash generation supporting dividend sustainability
- Potential 10% upside to fair value
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable dividend yield with moderate payout ratio
- Low beta and defensive balance sheet
- Cyclical exposure in the industrial sector
Key Metrics & Analysis
Financial Health
Revenue Growth1.50%
Profit Margin10.84%
P/E Ratio13.0
ROE13.96%
ROA8.92%
Debt/Equity1.22
P/B Ratio1.8
Op. Cash Flow$66.0M
Free Cash Flow$44.9M
Industry P/E31.7
Technical Analysis
TrendBullish
RSI61.6
Support$19.99
Resistance$21.90
MA 20$20.75
MA 50$20.55
MA 200$19.36
MACDBullish
VolumeIncreasing
Fear & Greed Index89.91
Valuation
Fair Value$27.12
Target Price$24.00
Upside/Downside10.80%
GradeUndervalued
TypeValue
Dividend Yield4.62%
Risk Assessment
Beta0.28
Volatility25.07%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.